Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues

Tietze, F. (1969) · Analytical Biochemistry · doi:10.1016/0003-2697(69)90064-5 · Cited by 6,077 · see citing works

GLUTATHIONE TRANSFERASES

Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,565 · see citing works

Mitochondrial diseases in man and mouse

Wallace, D. C. (1999) · Science · doi:10.1126/science.283.5407.1482 · Cited by 3,060 · see citing works

Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species

Kane, D. J., Sarafian, T. A., Anton, R., Hahn, H., Gralla, E. B., Valentine, J. S., Örd, T., & Bredesen, D. E. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671 · see citing works

Biologic and pharmacologic regulation of mammalian glutathione synthesis

Griffith, O. W. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00176-8 · Cited by 1,195 · see citing works

Glutathione S-Transferase Polymorphisms and Their Biological Consequences

Hayes, J. D., & Strange, R. C. (2000) · Pharmacology · doi:10.1159/000028396 · Cited by 1,004 · see citing works

Frontal lobe and cognitive development

Fuster, J. M. (2002) · Journal of Neurocytology · doi:10.1023/a:1024190429920 · Cited by 916 · see citing works

Glutathione Pathways in the Brain

Dringen, R., & Hirrlinger, J. (2003) · Biological Chemistry · doi:10.1515/bc.2003.059 · Cited by 597 · see citing works

Textbook of psychopharmacology

Edwards, G. (1975) · Nature · doi:10.1038/258648b0 · Cited by 583 · see citing works

Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder

Rajkowska, G., Halaris, A. E., & Selemon, L. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01080-0 · Cited by 572 · see citing works

Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder

Konradi, C. L., Eaton, M. E., MacDonald, M. L., Walsh, J. P., Benes, F. M., & Heckers, S. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.300 · Cited by 499 · see citing works

The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNS

Chen, G., Zeng, W., YUAN, P., Huang, L., Jiang, Y., Zhao, Z., & Manji, H. K. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.720879.x · Cited by 489 · see citing works

Long Term Lithium Treatment Suppresses p53 and Bax Expression but Increases Bcl-2 Expression

Chen, R., & Chuang, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6039 · Cited by 470 · see citing works

Brain Metabolic Alterations in Medication-Free Patients With BipolarDisorder

Dager, S. R., Friedman, S. D., Parow, A. M., Demopulos, C. M., Stoll, A. L., Lyoo, I. K., Dünner, D. L., & Renshaw, P. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.5.450 · Cited by 453 · see citing works

The Endoplasmic Reticulum Stress-Responsive Protein GRP78 Protects Neurons Against Excitotoxicity and Apoptosis: Suppression of Oxidative Stress and Stabilization of Calcium Homeostasis

Yu, Z., Luo, H., Fu, W., & Mattson, M. P. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7002 · Cited by 438 · see citing works

Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N -methyl- d -aspartate receptor-mediated calcium influx

Nonaka, S., Hough, C. J., & Chuang, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2642 · Cited by 430 · see citing works

Suicidal Behaviour in Bipolar Disorder

Tondo, L., Isacsson, G., & Baldessarini, R. J. (2003) · CNS Drugs · doi:10.2165/00023210-200317070-00003 · Cited by 399 · see citing works

The functional neuroanatomy of mood disorders

Soares, J. C., & Mann, J. J. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00016-2 · Cited by 379 · see citing works

Endoplasmic Reticulum Chaperones GRP78 and Calreticulin Prevent Oxidative Stress, Ca2+ Disturbances, and Cell Death in Renal Epithelial Cells

Liu, H., Bowes, R. C., van de Water, B., Sillence, C., Nagelkerke, J. F., & Stevens, J. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.35.21751 · Cited by 373 · see citing works

Neuroimaging abnormalities in the subgenual prefrontal cortex: implications for the pathophysiology of familial mood disorders

Drevets, W. C., Öngür, D., & Price, J. L. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000370 · Cited by 352 · see citing works

Antioxidant Role of Glutathione S -Transferases: Protection Against Oxidant Toxicity and Regulation of Stress-Mediated Apoptosis

Sharma, R., Yang, Y., Sharma, A., Awasthi, S., & Awasthi, S. (2004) · Antioxidants and Redox Signaling · doi:10.1089/152308604322899350 · Cited by 319 · see citing works

Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: An essential step for neuroprotection against glutamate excitotoxicity

Hashimoto, R., Takei, N., Shimazu, K., Christ, L. A., Lu, B., & Chuang, D. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00217-4 · Cited by 257 · see citing works

The Enzymes of Glutathione Synthesis: γ‐Glutamylcysteine Synthetase

Griffith, O. W., & Mulcahy, R. (1999) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123195.ch7 · Cited by 254 · see citing works

Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats

Nonaka, S., & Chuang, D. (1998) · Neuroreport · doi:10.1097/00001756-199806220-00031 · Cited by 250 · see citing works

Regulation of glutathione synthesis

Lu, S. C.-L. (2001) · Current topics in cellular regulation · doi:10.1016/s0070-2137(01)80004-2 · Cited by 240 · see citing works

Effects of lithium and valproate on amphetamineinduced oxidative stress generation in an animal model of mania

Frey, B. N., Valvassori, S. S., Réus, G. Z., Martins, M. R., Petronilho, F. C., Bardini, K., Dal‐Pizzol, F., Kapczinski, F. P., & Quevedo, J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0637 · Cited by 238 · see citing works

Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder

Sun, X., Wang, J., Tseng, M., & Young, L. T. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0623 · Cited by 238 · see citing works

Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy

Kato, T., Takahashi, S., Shioiri, T., & Inubushi, T. (1993) · Journal of Affective Disorders · doi:10.1016/0165-0327(93)90097-4 · Cited by 227 · see citing works

Chronic Treatment with Mood Stabilizers Lithium and Valproate Prevents Excitotoxicity by Inhibiting Oxidative Stress in Rat Cerebral Cortical Cells

Shao, L., Young, L. T., & Wang, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.052 · Cited by 218 · see citing works

Textbook of Psychopharmacology

(1995) · Nature Medicine · doi:10.1038/nm0895-834 · Cited by 178 · see citing works

Bcl-2 prevents mitochondrial permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides

Kowaltowski, A. J., Vercesi, A. E., & Fiskum, G. M. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400722 · Cited by 159 · see citing works

Reduced intracellular pH in the basal ganglia and whole brain measured by 31P‐MRS in bipolar disorder

HAMAKAWA, H., Murashita, J., Yamada, N., Inubushi, T., Kato, N., & Kato, T. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2004.01197.x · Cited by 137 · see citing works

Excitotoxicity, Oxidative Stress, and the Neuroprotective Potential of Melatonin

Skaper, S. D., Floreani, M., Ceccon, M., Facci, L., & Giusti, P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07985.x · Cited by 135 · see citing works

Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder

Kato, T., Stine, O. C., McMahon, F. J., & Crowe, R. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00012-7 · Cited by 124 · see citing works

Decreased temporal lobe phosphomonoesters in bipolar disorder

Deicken, R. F., Weiner, M. W., & Fein, G. (1995) · Journal of Affective Disorders · doi:10.1016/0165-0327(94)00089-r · Cited by 119 · see citing works

Cortical Influences in Emotion

Heilman, K. M., & Gilmore, R. L. (1998) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199809000-00005 · Cited by 119 · see citing works

Cytoprotection by lithium and valproate varies between cell types and cellular stresses

Lai, J. S., Zhao, C., Warsh, J. J., & Li, P. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.076 · Cited by 116 · see citing works

Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells

Wang, J., Azzam, J. E., & Young, L. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00655-3 · Cited by 107 · see citing works

The nature of bipolar disorder.

Manji, H. K., & Lenox, R. H. (2000) · PubMed · Cited by 104 · see citing works

Differential Display PCR Reveals Novel Targets for the Mood-Stabilizing Drug Valproate Including the Molecular Chaperone GRP78

Wang, J., Bown, C. D., & Young, L. T. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12177-3 · Cited by 96 · see citing works

Mood stabilizing drug lithium increases expression of endoplasmic reticulum stress proteins in primary cultured rat cerebral cortical cells

Shao, L., Sun, X., Xu, L., Young, L. T., & Wang, J. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.07.007 · Cited by 85 · see citing works

Glutathione S‐transferase is a novel target for mood stabilizing drugs in primary cultured neurons

Wang, J., Shao, L., Sun, X., & Young, L. T. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02276.x · Cited by 76 · see citing works

Chronic valproate treatment increases expression of endoplasmic reticulum stress proteins in the rat cerebral cortex and hippocampus

Chen, B., Wang, J. F., & Young, L. T. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00878-7 · Cited by 68 · see citing works

Inhibition of glycogen synthase kinase-3 protects cells from intrinsic but not extrinsic oxidative stress

King, T. D., & Jope, R. S. (2005) · Neuroreport · doi:10.1097/00001756-200504250-00016 · Cited by 66 · see citing works

Characterization of the Bifunctional γ-Glutamate-cysteine Ligase/Glutathione Synthetase (GshF) of Pasteurella multocida

Vergauwen, B., Vos, D. E. D., & BEEUMEN, J. J. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509517200 · Cited by 64 · see citing works

Cytoprotective effect is one of common action pathways for antidepressants.

Li, Y., Liu, Y., Huang, W.-C., & Luo, Z.-P. (2003) · PubMed · Cited by 59 · see citing works

Oxidative signaling and glutathione synthesis

Forman, H. J., & Dickinson, D. A. (2003) · BioFactors · doi:10.1002/biof.5520170101 · Cited by 56 · see citing works

Regulation of GAP-43 expression by chronic desipramine treatment in rat cultured hippocampal cells

Chen, B., Wang, J.-F., Sun, X., & Young, L. T. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01551-2 · Cited by 50 · see citing works

Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells

Wang, J., Asghari, V., Rockel, C. P., & Young, L. T. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00627-7 · Cited by 46 · see citing works

Attenuation of N-methyl-d-aspartate-mediated cytoplasmic vacuolization in primary rat hippocampal neurons by mood stabilizers

Bown, C. D., Wang, J., & Young, L. T. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00743-1 · Cited by 37 · see citing works

Lamotrigine Increases Gene Expression of GABA-A Receptor β3 Subunit in Primary Cultured Rat Hippocampus Cells

Wang, J. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00385-2 · Cited by 36 · see citing works

Regional expression of Bcl-2 mRNA and mitochondrial cytochrome c release after experimental brain injury in the rat

Dong, G.-X., Singh, D. K., Dendle, P., & Prasad, R. M. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02379-4 · Cited by 18 · see citing works

Desipramine antagonized corticosterone-induced apoptosis in cultured PC12 cells.

Li, Y.-F., & Luo, Z.-P. (2002) · PubMed · Cited by 15 · see citing works

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178 · see citing works

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · see citing works

Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders

Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145710000805 · Cited by 594 · see citing works

Impaired mitochondrial function in psychiatric disorders

Manji, H. K., Kato, T., Prospero, N. A. D., Ness, S. L., Beal, M. F., Krams, M., & Chen, G. (2012) · Nature reviews. Neuroscience · doi:10.1038/nrn3229 · Cited by 478 · see citing works

Mitochondrial Dysfunction and Psychiatric Disorders

Rezin, G. T., Amboni, G., Zugno, A. I., Quevedo, J., & STRECK, E. L. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9865-8 · Cited by 443 · see citing works

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00714.x · Cited by 370 · see citing works

Oxidative stress in anxiety and comorbid disorders

Hovatta, I., Juhila, J., & Donner, J. (2010) · Neuroscience Research · doi:10.1016/j.neures.2010.08.007 · Cited by 365 · see citing works

Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia

Wang, J., Shao, L., Sun, X., & Young, L. T. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00717.x · Cited by 270 · see citing works

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

Morris, G., & Berk, M. (2015) · BMC Medicine · doi:10.1186/s12916-015-0310-y · Cited by 245 · see citing works

Biochemical, Molecular and Epigenetic Mechanisms of Valproic Acid Neuroprotection

Monti, B., Polazzi, E., & Contestabile, A. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010095 · Cited by 241 · see citing works

Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

Kim, Y., Vadodaria, K. C., Lenkei, Z., Kato, T., Gage, F. H., Marchetto, M. C., & Santos, R. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7606 · Cited by 189 · see citing works

Glutathione: a novel treatment target in psychiatry

Berk, M., Ng, F., Dean, O., Dodd, S., & Bush, A. I. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.05.001 · Cited by 183 · see citing works

Vitamin D and Depression: Cellular and Regulatory Mechanisms

Berridge, M. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013227 · Cited by 186 · see citing works

Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder

Quiroz, J. A., Gray, N. A., Kato, T., & Manji, H. K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301671 · Cited by 170 · see citing works

The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence

Zuccoli, G. S., Saia-Cereda, V. M., Nascimento, J. M., & Martins-de-Souza, D. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00493 · Cited by 157 · see citing works

Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness

Che, Y., Wang, J.-F., Shao, L., & Young, L. T. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.090083 · Cited by 155 · see citing works

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

Lee, S., Lee, S.-J., Han, C., Patkar, A. A., Masand, P. S., & Pae, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.008 · Cited by 145 · see citing works

The role of hippocampus in the pathophysiology of bipolar disorder

Frey, B. N., Andreazza, A. C., Nery, F. G., Martins, M. R., Quevedo, J., Soares, J. C., & Kapczinski, F. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282df3cde · Cited by 162 · see citing works

The role of mitochondria in mood disorders: from physiology to pathophysiology and to treatment

Giménez-Palomo, A., Dodd, S., Anmella, G., Carvalho, A. F., Scaini, G., Quevedo, J., Pacchiarotti, I., Vieta, E., & Berk, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.546801 · Cited by 140 · see citing works

Novel Therapeutic Targets in Depression and Anxiety: Antioxidants as a Candidate Treatment

Xu, Y., Wang, C., Klabnik, J., & Donnell, J. O. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120231448 · Cited by 139 · see citing works

The Neuroprotective Effect of Curcumin and Nigella sativa Oil Against Oxidative Stress in the Pilocarpine Model of Epilepsy: A Comparison with Valproate

Ezz, H. S. A., Khadrawy, Y. A., & Noor, N. A. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0544-9 · Cited by 130 · see citing works

Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: A potential mediator between mitochondria and immune-activation

Kim, H. K., Andreazza, A. C., Elmi, N., Chen, W., & Young, L. T. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.10.015 · Cited by 128 · see citing works

Role of oxidative stress in the pathophysiology of bipolar disorder

Steckert, A. V., Valvassori, S. S., Moretti, M., Dal‐Pizzol, F., & Quevedo, J. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0195-2 · Cited by 125 · see citing works

Is Lithium a Micronutrient? From Biological Activity and Epidemiological Observation to Food Fortification

Szklarska, D., & Rzymski, P. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1455-2 · Cited by 120 · see citing works

Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges

Kim, Y., Santos, R., Gage, F. H., & Marchetto, M. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00030 · Cited by 120 · see citing works

Antioxidant defense in schizophrenia and bipolar disorder: A meta-analysis of MRS studies of anterior cingulate glutathione

Das, T. K., Javadzadeh, A., Dey, A., Sabesan, P., Théberge, J., Raduà, J., & Palaniyappan, L. K. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.006 · Cited by 114 · see citing works

Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: Restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β

Correa, F., Mallard, C. E., Nilsson, M., & Sandberg, M. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.06.016 · Cited by 106 · see citing works

Putative neuroprotective agents in neuropsychiatric disorders

Dodd, S., Maes, M. H. J., Anderson, G., Dean, O. M., Moylan, S., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.007 · Cited by 105 · see citing works

Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches

Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103 · see citing works

Molecular neurobiology of bipolar disorder: a disease of ‘mood-stabilizing neurons’?

Kato, T. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.07.007 · Cited by 102 · see citing works

Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy

Fourcade, S., Ruíz, M., Guilera, C., Hahnen, E., Brichta, L., Naudí, A., Portero‐Otín, M., Dacremont, G., Cartier, N., Wanders, R. J. A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq082 · Cited by 100 · see citing works

The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress

Martinc, B., Grabnar, I., & Vovk, T. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499447 · Cited by 100 · see citing works

Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia

Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., Yatham, L. N., & Young, L. T. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000617 · Cited by 99 · see citing works

The role of mitochondrial dysfunction in psychiatric disease

Scaglia, F. (2010) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.115 · Cited by 96 · see citing works

Seizure-Induced Oxidative Stress in Status Epilepticus: Is Antioxidant Beneficial?

Lin, T., Chen, S., Lin, K.-J., & Chuang, Y. (2020) · Antioxidants · doi:10.3390/antiox9111029 · Cited by 94 · see citing works

Potential application of lithium in Parkinson's and other neurodegenerative diseases

Lazzara, C. A., & Kim, Y. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00403 · Cited by 93 · see citing works

The Role of Reactive Species in Epileptogenesis and Influence of Antiepileptic Drug Therapy on Oxidative Stress

Martinc, B., Grabnar, I., & Vovk, T. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143504 · Cited by 88 · see citing works

Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders

STRECK, E. L., Gonçalves, C. L., Furlanetto, C. B., Scaini, G., Dal‐Pizzol, F., & Quevedo, J. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1224 · Cited by 82 · see citing works

Changes in the anti-oxidant system in adult epilepsy patients receiving anti-epileptic drugs

Işık, M., Demir, Y., Kırıcı, M., Demir, R., Şimşek, F., & Beydemir, Ş. (2015) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2015.1026912 · Cited by 81 · see citing works

Effect of valproic acid on acute lung injury in a rodent model of intestinal ischemia reperfusion

Kim, K., Li, Y., Jin, G., Chong, W., Liu, B., Lu, J., Lee, K., DeMoya, M. A., Velmahos, G. C., & Alam, H. B. (2011) · Resuscitation · doi:10.1016/j.resuscitation.2011.07.029 · Cited by 81 · see citing works

Decreased global methylation in patients with bipolar disorder who respond to lithium

Huzayyin, A. A. S., Andreazza, A. C., Turecki, G., Cruceanu, C., Rouleau, G. A., Alda, M., & Young, L. T. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001569 · Cited by 80 · see citing works

Cerebrospinal Fluid Metabolome in Mood Disorders-Remission State has a Unique Metabolic Profile

Kaddurah-Daouk, R., Yuan, P., Boyle, S. H., Matson, W., Wang, Z., Zeng, Z. B., Zhu, H., Dougherty, G. G., Yao, J. K., Chen, G., et al. (2012) · Scientific Reports · doi:10.1038/srep00667 · Cited by 76 · see citing works

Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder

Scaini, G., Andrews, T., Lima, C. N. D. C., Benevenuto, D., STRECK, E. L., & Quevedo, J. (2020) · Mitochondrion · doi:10.1016/j.mito.2020.12.002 · Cited by 77 · see citing works

Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development

Nierenberg, A. A., Kansky, C., Brennan, B. P., Shelton, R. C., Perlis, R. H., & Iosifescu, D. V. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412449303 · Cited by 76 · see citing works

Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review

Sher, Y. I., Cramer, A. C. M., Ament, A., Lolak, S., & Maldonado, J. R. (2015) · Psychosomatics · doi:10.1016/j.psym.2015.09.008 · Cited by 76 · see citing works

Chronic lithium treatment magnifies learning in rats

Nocjar, C., Hammonds, M. D., & Shim, S. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.063 · Cited by 73 · see citing works

Parkinson’s Disease: Potential Actions of Lithium by Targeting the WNT/β-Catenin Pathway, Oxidative Stress, Inflammation and Glutamatergic Pathway

Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2021) · Cells · doi:10.3390/cells10020230 · Cited by 71 · see citing works

Multiple levels of impaired neural plasticity and cellular resilience in bipolar disorder: Developing treatments using an integrated translational approach

Machado‐Vieira, R., Soeiro‐de‐Souza, M. G., Richards, E. M., Teixeira, A. L., & Zarate, C. A. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.830775 · Cited by 70 · see citing works

Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome

Filosa, S., Pecorelli, A., D’Esposito, M., Valacchi, G., & Hayek, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.019 · Cited by 69 · see citing works

Novel Insight to Neuroprotective Potential of Curcumin: A Mechanistic Review of Possible Involvement of Mitochondrial Biogenesis and PI3/Akt/ GSK3 or PI3/Akt/CREB/BDNF Signaling Pathways.

Kandezi, N., Mohammadi, M., Ghaffari, M., Gholami, M., Motaghinejad, M., & Safari, S. (2020) · PubMed Central · doi:10.22088/ijmcm.bums.9.1.1 · Cited by 67 · see citing works

Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy

Godlewska, B. R., Yip, S. W., Near, J., Goodwin, G. M., & Cowen, P. J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3244-0 · Cited by 66 · see citing works

Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy

Yiş, U., Seçkin, E., Kurul, S. H., Kuralay, F., & Dırık, E. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.02.003 · Cited by 64 · see citing works

The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes

Shao, L., Cui, J., Young, L. T., & Wang, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.10.041 · Cited by 63 · see citing works

Oxidative stress in bipolar and schizophrenia patients

Tunçel, Ö. K., Sarísoy, G., Bilgici, B., Pazvantoğlu, O., Çetin, E., Ünverdi, E., Avcı, B., & Böke, Ö. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.046 · Cited by 62 · see citing works

Melamine induced cognitive impairment associated with oxidative damage in rat's hippocampus

An, L., Li, Z., Yang, Z. R., & Zhang, T. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.04.009 · Cited by 62 · see citing works

Potential Mechanisms Involved in the Prevention of Neurodegenerative Diseases by Lithium

Camins, A., Verdaguer, E., Junyent, F., Yeste‐Velasco, M., Pelegrı́, C., Vilaplana, J., & Pallàs, M. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2009.00086.x · Cited by 59 · see citing works

Cerebrospinal fluid oxidative stress metabolites in patients with bipolar disorder and healthy controls: a longitudinal case-control study

Knorr, U. B., Simonsen, A. H., Roos, P., Weimann, A., Henriksen, T., Christensen, E. M., Vinberg, M., Mikkelsen, R. L., Kirkegaard, T., Jensen, R., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0664-6 · Cited by 57 · see citing works

Involvement of glutathione, ERK1/2 phosphorylation and BDNF expression in the antidepressant-like effect of zinc in rats

Franco, J. L. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.11.012 · Cited by 57 · see citing works

Evaluation of Gender-Related Differences in Various Oxidative Stress Enzymes in Mice

Chen, Y., Ji, L., Liu, T., & Wang, Z. (2012) · The Chinese Journal of Physiology · doi:10.4077/cjp.2011.amm080 · Cited by 54 · see citing works

Defects of Mitochondrial Electron Transport Chain in Bipolar Disorder: Implications for Mood-Stabilizing Treatment

Wang, J. (2007) · The Canadian Journal of Psychiatry · doi:10.1177/070674370705201202 · Cited by 52 · see citing works

Is lithium neuroprotective? An updated mechanistic illustrated review

Ghanaatfar, F., Ghanaatfar, A., Isapour, P., Farokhi, N., Bozorgniahosseini, S., Javadi, M., Gholami, M., Ulloa, L., Coleman‐Fuller, N., & Motaghinejad, M. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12826 · Cited by 51 · see citing works

Targeting histone deacetylases for the treatment of disease

Lawless, M. W., Norris, S., O'Byrne, K. J., & Gray, S. G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00571.x · Cited by 49 · see citing works

Is bipolar disorder a mitochondrial disease?

Young, L. T. (2007) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0715 · Cited by 50 · see citing works

Enhanced Endothelial Cell Senescence by Lithium-induced Matrix Metalloproteinase-1 Expression

Struewing, I. T., Durham, S. N., Barnett, C. D., & Mao, C. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.001735 · Cited by 47 · see citing works

Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain

Valvassori, S. S., Dal-Pont, G. C., Resende, W. R., Jornada, L. K., Peterle, B. R., Machado, A. G., Farias, H. R., de Souza, C. T., Carvalho, A. F., & Quevedo, J. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.015 · Cited by 47 · see citing works

Oxidative Stress in Older Patients with Bipolar Disorder

Andreazza, A. C., Gildengers, A. G., Rajji, T. K., Zuzarte, P., Mulsant, B. H., & Young, L. T. (2014) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2014.05.008 · Cited by 46 · see citing works

Neuroprotective effects of chronic exposure of SH-SY5Y to low lithium concentration involve glycolysis stimulation, extracellular pyruvate accumulation and resistance to oxidative stress

Nciri, R., Desmoulin, F., Allagui, M. S., Murat, J., Feki, A. E., Vincent, C., & Croute, F. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000132 · Cited by 46 · see citing works

Epigenetic Treatment of Neurological Disease

Gray, S. G. (2011) · Epigenomics · doi:10.2217/epi.11.67 · Cited by 45 · see citing works

Synergistic effects of GSK-3β and HDAC inhibitors in intracerebroventricular streptozotocin-induced cognitive deficits in rats

Sharma, S., & Taliyan, R. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1081-2 · Cited by 44 · see citing works

Magnesium supplementation enhances the anticonvulsant potential of valproate in pentylenetetrazol-treated rats

Safar, M. M., Abdallah, D. M., Arafa, N. M. S., & Abdel-Aziz, M. T. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.076 · Cited by 42 · see citing works

Effects of antidepressants on mRNA levels of antioxidant enzymes in human monocytic U-937 cells

Schmidt, A. J., Heiser, P., Hemmeter, U. M., Krieg, J.-C., & Vedder, H. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.024 · Cited by 40 · see citing works

Targeting Oxidative Stress Component in the Therapeutics of Epilepsy

Azam, F., Prasad, M. V. V., & Thangavel, N. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612800229224 · Cited by 40 · see citing works

Frontal lobe bioenergetic metabolism in depressed adolescents with bipolar disorder: a phosphorus‐31 magnetic resonance spectroscopy study

Shi, X., Kondo, D. G., Sung, Y., Hellem, T., Fiedler, K. K., Jeong, E., Huber, R. S., & Renshaw, P. F. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01040.x · Cited by 39 · see citing works

Lithium toxicity and expression of stress-related genes or proteins in A549 cells

Allagui, M. S., Vincent, C., Feki, A. E., Gaubin, Y., & Croute, F. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.04.007 · Cited by 38 · see citing works

Assessing oxidative pathway genes as risk factors for bipolar disorder

Fullerton, J. M., Tiwari, Y., Agahi, G., Heath, A., Berk, M., Mitchell, P. B., & Schofield, P. R. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00834.x · Cited by 37 · see citing works

Long-term Exposure to Low Lithium Concentrations Stimulates Proliferation, Modifies Stress Protein Expression Pattern and Enhances Resistance to Oxidative Stress in SH-SY5Y Cells

Allagui, M. S., Nciri, R., Rouhaud, M. F., Murat, J. C., Feki, A. E., Croute, F., & Vincent, C. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9804-8 · Cited by 36 · see citing works

Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons

Scola, G., Kim, H. K., Young, L. T., Salvador, M. M., & Andreazza, A. C. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3565-7 · Cited by 36 · see citing works

The Relationship between the Number of Manic Episodes and Oxidative Stress Indicators in Bipolar Disorder

Akarsu, S., Bolu, A., Aydemir, E., Zincir, S. B., Kurt, Y. G., Zincir, S., Erdem, M., & Uzun, Ö. (2018) · Psychiatry Investigation · doi:10.30773/pi.2016.12.31 · Cited by 35 · see citing works

Baicalein attenuates proteasome inhibition-induced apoptosis by suppressing the activation of the mitochondrial pathway and the caspase-8- and Bid-dependent pathways

Jung, E. B., & Lee, C. S. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.039 · Cited by 35 · see citing works

Targeting Histone Deacetylases for the Treatment of Huntington's Disease

Gray, S. G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00184.x · Cited by 34 · see citing works

Molecular Validation of the Acute Phencyclidine Rat Model for Schizophrenia: Identification of Translational Changes in Energy Metabolism and Neurotransmission

Ernst, A., Ma, D., García‐Pérez, I., Tsang, T. M., Kluge, W. F., Schwarz, E., Guest, P. C., Holmes, E. C., Sarnyai, Z., & Bahn, S. (2012) · Journal of Proteome Research · doi:10.1021/pr300197d · Cited by 34 · see citing works

Lithium for Older Adults with Bipolar Disorder

Shulman, K. I. (2010) · Drugs & Aging · doi:10.2165/11537700-000000000-00000 · Cited by 33 · see citing works

Oxidatively-induced DNA damage and base excision repair in euthymic patients with bipolar disorder

Ceylan, D., Tuna, G., Kırkalı, G., Tunca, Z., Can, G., Arat, H. E., Kant, M., Dizdaroğlu, M., & Özerdem, A. (2018) · DNA repair · doi:10.1016/j.dnarep.2018.03.006 · Cited by 32 · see citing works

Effect of mood stabilizers on gene expression in lymphoblastoid cells

Sugawara, H., Iwamoto, K., Bundo, M., Ishiwata, M., Ueda, J., Kakiuchi, C., Ishigooka, J., & Kato, T. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0340-8 · Cited by 33 · see citing works

Mitochondrial Dysfunction as a Biomarker of Illness State in Bipolar Disorder: A Critical Review

Giménez‐Palomo, A., Gracia, H. A., de Juan, O., Olivier, L., Ochandiano, I., Ilzarbe, L., Valentí, M., Stoppa, A., Llach, C.-D., Pacenza, G., et al. (2024) · Brain Sciences · doi:10.3390/brainsci14121199 · Cited by 33 · see citing works

Potential Role of Glutathione Antioxidant Pathways in the Pathophysiology and Adjunct Treatment of Psychiatric Disorders

Poladian, N., Navasardyan, I., Narinyan, W., Orujyan, D., & Venketaraman, V. (2023) · Clinics and Practice · doi:10.3390/clinpract13040070 · Cited by 31 · see citing works

Targeting Huntington’s disease through histone deacetylases

Gray, S. G. (2011) · Clinical Epigenetics · doi:10.1007/s13148-011-0025-7 · Cited by 31 · see citing works

Pharmacological evidence for lithium-induced neuroprotection against methamphetamine-induced neurodegeneration via Akt-1/GSK3 and CREB-BDNF signaling pathways.

Mehrafza, S., Kermanshahi, S., Mostafidi, S., Motaghinejad, M., Motevalian, M., & Fatima, S. (2019) · PubMed Central · doi:10.22038/ijbms.2019.30855.7442 · Cited by 31 · see citing works

Effects of acute and chronic quercetin administration on methylphenidate-induced hyperlocomotion and oxidative stress

Kanazawa, L. K. S., Vecchia, D. D., Wendler, E., Hocayen, P. D. A. S., Beirão, P. S. L., de Mélo, M. L., Lívero, F. A. D. R., Corso, C. R., Stipp, M. C., Acco, A., et al. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.01.007 · Cited by 30 · see citing works

Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine

Khanra, S., Reddy, P. H., Giménez‐Palomo, A., Park, C. H. J., Panizzutti, B., McCallum, M., Arumugham, S. S., Shreekantiah, U., Debnath, M., Das, B., et al. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02134-8 · Cited by 28 · see citing works

Evaluation of glutathione metabolism in NMDA preconditioning against quinolinic acid-induced seizures in mice cerebral cortex and hippocampus

Vandresen-Filho, S., Herculano, B., Franco, J. L., Boeck, C. R., Dafré, A. L., & Tasca, C. I. (2007) · Brain Research · doi:10.1016/j.brainres.2007.09.091 · Cited by 26 · see citing works

Mitochondrial dysfunction and lipid peroxidation in rat frontal cortex by chronic NMDA administration can be partially prevented by lithium treatment

Kim, H. K., Isaacs-Trepanier, C., Elmi, N., Rapoport, S. I., & Andreazza, A. C. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.001 · Cited by 26 · see citing works

Vitamin U, a novel free radical scavenger, prevents lens injury in rats administered with valproic acid

Tunalı, S., Kahraman, S., & Yanardağ, R. (2014) · Human & Experimental Toxicology · doi:10.1177/0960327114561665 · Cited by 24 · see citing works

Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays

Mariotti, V., Melissari, E., Amar, S., Conte, A., Belmaker, R. H., Agam, G., & Pellegrini, S. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009225 · Cited by 24 · see citing works

Mitochondrial Dysfunction and Oxidative Stress

Kato, T., Kapczinski, F. P., & Berk, M. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch18 · Cited by 24 · see citing works

α-Lipoic Acid Interaction with Dopamine D2 Receptor-Dependent Activation of the Akt/GSK-3β Signaling Pathway Induced by Antipsychotics: Potential Relevance for the Treatment of Schizophrenia

Deslauriers, J., Desmarais, C., Sarret, P., & Grignon, S. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9884-4 · Cited by 23 · see citing works

Modulation of Hippocampal Antioxidant Defense System in Chronically Stressed Rats by Lithium

Popović, N., Stojiljković, V., Pejić, S., Todorović, A., Pavlović, I., Gavrilović, L., & Pajović, S. B. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8745376 · Cited by 22 · see citing works

The effects of vitamin B6 on lens antioxidant system in valproic acid-administered rats

Tunalı, S. (2013) · Human & Experimental Toxicology · doi:10.1177/0960327113506233 · Cited by 22 · see citing works

Chronic treatment with the mood-stabilizing drug lithium up-regulates nuclear factor E2-related factor 2 in rat pheochromocytoma PC12 cells in vitro

Rizak, J. D., Tan, H. T., Zhu, H., & Wang, J. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.036 · Cited by 22 · see citing works

GBR 12909 administration as an animal model of bipolar mania: time course of behavioral, brain oxidative alterations and effect of mood stabilizing drugs

Queiroz, A. I. G., de Araújo, M. M., Araújo, T. D. S., de Souza, G. C., Cavalcante, L. M., Machado, M. D. J. S., de Lucena, D. F., Quevedo, J., & Macêdo, D. S. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9697-6 · Cited by 22 · see citing works

The Role of Glutathione Metabolism in the Neuroprotective Effect of Mood Stabilizers

Pasiliao, C. C. (2011) · TSpace (University of Toronto)

Cytoprotection by lithium and valproate varies between cell types and cellular stresses

Lai, J. S., Zhao, C., Warsh, J. J., & Li, P. P. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.076 · Cited by 116 · see citing works

The Antiapoptotic Actions of Mood Stabilizers: Molecular Mechanisms and Therapeutic Potentials

Chuang, D. M. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1344.018 · Cited by 196 · see citing works

The Antiapoptotic Actions of Mood Stabilizers

CHUANG, D. (2005) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2005.tb00026.x · Cited by 200 · see citing works

Chronic Treatment with Mood Stabilizers Lithium and Valproate Prevents Excitotoxicity by Inhibiting Oxidative Stress in Rat Cerebral Cortical Cells

Shao, L., Young, L. T., & Wang, J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.04.052 · Cited by 218 · see citing works